Skip to main content
Caplight Logo









Sword Bio

Sword Bio

Private
Chicago, IllinoisHealthcare & Life Scienceshttps://swordbio.com/

Last Round

Seed

Jun 26, 2025

Est. Valuation

$11.7M

Total Funding Raised

$1.7M

Company Overview

Sword Bio is a biotechnology company that operates as a bioanalytical contract research organization (CRO) providing assay development, validation, and sample analysis services to support pharmaceutical and biotech companies in drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

contract research organizationCRObioanalytical servicesassay developmentligand binding assaysLBApharmacokinetic assaysPK assaysimmunogenicity assaysbiomarker analysiscell-based assaysdrug developmentpreclinical testingclinical trialslab outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Sword Bio Comparables

Compare Sword Bio with similar companies based on industry and business-model similarity.

Sword Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
NorthEast BioAnalytical Laboratories LLC
88%
Meadowhawk Biolabs, Inc.
85%
Alturas Analytics, Inc.
82%

Sword Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 26, 2025
Pre SeedJun 26, 2023
Series BMar 5, 2007
Series AOct 13, 2006

Key People

Founding team and executive leadership

Matthew Langevin

COO

Executive Team

Sword Bio Investors

Notable investors and investment history

Sword Bio investors
InvestorRounds
Jumpstart NJ Angel NetworkAngel, Pre Seed
Keiretsu ForumAngel, Pre Seed
Elevate VenturesAngel, Pre Seed
Tech Council VenturesAngel, Pre Seed, Series A, Series B
Heartland AngelsAngel, Pre Seed
Angel Physicians FundPre Seed
Calvert Research and ManagementSeries A, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 26, 2025

    $4M raised in Seed round.

  • Jun 26, 2023

    $50K round from Elevate Ventures and Tech Council Ventures.

Sword Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Sword Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Sword Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersChicago, Illinois
Employee Range28
Year Founded2017
Last FundingJun 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?